secwatch.observer — SEC 8-K summary
======================================

Issuer:     Theravance Biopharma, Inc. (TBPH)
CIK:        0001583107
Form:       8-K
Filed at:   2023-04-17T23:59:59+00:00
Accession:  0001104659-23-045844
Event type: other
Sentiment:  neutral
Materiality: 0.00
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Theravance Biopharma presents at Needham Healthcare Conference; no material news disclosed
--------------------------------------------------------------------------------

- Management team presented at 22nd Annual Needham Virtual Healthcare Conference on April 17, 2023.
- Slide deck furnished as Exhibit 99.1 contains only a title slide; no financial or pipeline updates provided.
- Filing under Item 7.01 is for Regulation FD purposes and is not deemed filed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1583107/000110465923045844/0001104659-23-045844-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1583107/000110465923045844/tm2312970d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-045844

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer